Despite some negative media attention over the past five years due to cases of contaminated prescriptions, the Compounding Pharmacies industry has grown because it is indispensable in the broader healthcare sector. Drug shortages at pharmaceutical manufacturers have been a driver of growth over the period by boosting the need for custom-made drugs. Demographic changes, particularly the aging of the population, have also boosted industry revenue by increasing overall demand for pharmaceuticals. Growth is expected to continue over the next five years as visits to physicians increase, though growth will ultimately depend on the extent of demand for customized medications that address variations in patient allergies, dosage requirements and preferences.
This industry includes stores that make and sell compounded medications that are not commercially available. Compounded medications are those that are prescribed and written by physicians and prepared by pharmacists for individual patients. This industry does not include pharmacies that outsource compounding services to third parties.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.